Bard Associates Inc EYEPOINT PHARMACEUTICALS INC Transaction History

Bard Associates Inc

  • $267 Million
  • Q3 2024

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 11, 2021
SELL
N/A
-67,150 Closed
0 $0
Q3 2020

Nov 12, 2020
SELL
N/A
-15,750 Reduced 19.0%
67,150 $35,000
Q2 2020

Aug 13, 2020
BUY
N/A
3,500 Added 4.41%
82,900 $63,000
Q1 2020

May 13, 2020
SELL
N/A
-1,400 Reduced 1.73%
79,400 $81,000
Q4 2019

Feb 13, 2020
SELL
N/A
-83,800 Closed
0 $0
Q4 2019

Feb 13, 2020
BUY
N/A
80,800 New
80,800 $125,000
Q3 2019

Nov 14, 2019
SELL
N/A
-4,084 Reduced 4.65%
83,800 $152,000
Q2 2019

Aug 13, 2019
SELL
N/A
-300 Reduced 0.34%
87,884 $144,000
Q1 2019

May 13, 2019
SELL
N/A
-1,375 Reduced 1.54%
88,184 $158,000
Q4 2018

Feb 13, 2019
SELL
N/A
-1,500 Reduced 1.65%
89,559 $169,000
Q2 2018

Aug 15, 2018
BUY
N/A
91,059 New
91,059 $189,000
Track This Portfolio

Track Bard Associates Inc Portfolio

Follow Bard Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bard Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bard Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email